Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New insights into the etiology of age-related macular degeneration by a large genetic study

23.12.2015

Vision loss is a major burden for individuals. One of the leading causes of blindness in the elderly, Age-related Macular Degeneration, has been the target of a recent large international genetic study. The researchers, teaming up from around the world, aimed at unravelling the genetic catalogue of this disabling disease and identified new genetic regions relevant for the disease including one that is solely related to one subtype of this disease. Overall this large study provides insights into the genetic architecture of age-related macular degeneration and to future designs of genetic studies.

Age-related macular degeneration is a leading cause of blindness and severe disability that affects ten million older individuals worldwide. Therapy options are limited as currently therapy is only available for patients with one of the two disease subtypes, the so-called wet AMD, and even this therapy is symptomatic and no cure.

Unfortunately, it is not well understood by doctors or scientists why some people develop the disease while others remain disease-free. A major portion of the risk for AMD is the combination of genetic variants a person possesses; other risk factors include smoking or intensive light exposure. Finding the exact combination of genetic variants that puts people at risk for AMD is a difficult task that requires evaluating information from many thousands of individuals.

To get at the goal of better understanding the genetic influence of AMD risk, an international group of scientists from 26 study sites, including scientists from the University of Regensburg, joined forces to create and evaluate an extensive genome-wide data set that provided an excellent platform for a thorough search for gene regions that may influence AMD risk.

Using medical information and DNA from blood collected from more than 43,000 participants with and without AMD across the world, this group applied novel methods, that enabled the investigation of 12 million genetic variants. Not only did they find 34 gene regions for AMD including 16 that have not been described before. The new regions provide new clues to search for cures for this severe medical condition.

Most interestingly, this international group also identified a genetic region around the MMP9 gene that showed only an effect for the wet AMD, but not for dry AMD. This new knowledge might lead to a better understanding of why the therapy is more effective in some patients than in others.

The genetic make-up of a patient might also help explain why some treated patients suffer from a recurrence: To some extent this might be simply that the genetics hits again.

The investigators also had a specific focus on rare variants that alter the protein. If such a variant is found to be relevant for the disease, the mechanisms by what this variant exerts its effect is much easier to derive than for other variants: the specific change in the protein itself is then very likely the cause. While several such variants for AMD were depicted by this study, the study made also clear that these variants can be very rare and hard to depict.

This work also substantiates a strong role of the University of Regensburg. Researchers from the UR Institute of Human Genetics and the Department of Genetic Epidemiology have not only contributed study data, but also helped organize the international consortium (Prof. Weber) and co-lead and conducted (Prof. Heid and team) the analysis of this complex and high-dimensional data.

Overall, the results published in Nature Genetics (NG-A41068R2) help understand what makes individuals susceptible to the disease, which patients might benefit from a particular form of treatment, and what might be worthwhile next steps towards a cure that would be the hope of millions of patients (www.nature.com/ng/journal/v45/n4/full/ng.2578.html ).

Contact:
Prof. Dr. Iris Heid
Universität Regensburg
Chair for Genetic Epidemiology
Tel.: +49 (0)941 944-5210/5211
Iris.Heid@klinik.uni-regensburg.de

Alexander Schlaak | idw - Informationsdienst Wissenschaft
Further information:
http://www.uni-regensburg.de/

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>